Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

Clinical trial NCT07341919 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07341919
Sponsor: Rubens Camargo Siqueira
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive Macular Atrophy With Pseudodrusen (EMAP)Retinitis Pigmentosa (RP)

Start date: 2025-01-04
Primary completion: 2026-03-04
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.